United States Avanafil (Cas 330784-47-9) Market Report 2017

January 2017 | 99 pages | ID: UF28B726FD4EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Avanafil (Cas 330784-47-9)

Revenue, means the sales value of Avanafil (Cas 330784-47-9)

This report studies sales (consumption) of Avanafil (Cas 330784-47-9) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• VIVUS
• Menarini Group
• Auxilium Pharmaceuticals, Inc
• Sanofi
• Endo International
• JW Pharmaceutical

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• By Dosage
• 50mg
• 100mg
• 200mg
• By Purity
• ≥99%
• Other

Split by applications, this report focuses on sales, market share and growth rate of Avanafil (Cas 330784-47-9) in each application, can be divided into

• Pharmaceutical
• Other

Contents

United States Avanafil (Cas 330784-47-9) Market Report 2017

1 AVANAFIL (CAS 330784-47-9) OVERVIEW

1.1 Product Overview and Scope of Avanafil (Cas 330784-47-9)
1.2 Classification of Avanafil (Cas 330784-47-9)
  1.2.1 By Dosage
  1.2.2 50mg
  1.2.3 100mg
  1.2.4 200mg
  1.2.5 By Purity
  1.2.6 ≥99%
  1.2.7 Other
1.3 Application of Avanafil (Cas 330784-47-9)
  1.3.1 Pharmaceutical
  1.3.2 Other
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Avanafil (Cas 330784-47-9) (2011-2021)
  1.4.1 United States Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2021)
  1.4.2 United States Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2021)

2 UNITED STATES AVANAFIL (CAS 330784-47-9) COMPETITION BY MANUFACTURERS

2.1 United States Avanafil (Cas 330784-47-9) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Avanafil (Cas 330784-47-9) Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Avanafil (Cas 330784-47-9) Average Price by Manufactures (2015 and 2016)
2.4 Avanafil (Cas 330784-47-9) Market Competitive Situation and Trends
  2.4.1 Avanafil (Cas 330784-47-9) Market Concentration Rate
  2.4.2 Avanafil (Cas 330784-47-9) Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES AVANAFIL (CAS 330784-47-9) SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Avanafil (Cas 330784-47-9) Sales and Market Share by States (2011-2016)
3.2 United States Avanafil (Cas 330784-47-9) Revenue and Market Share by States (2011-2016)
3.3 United States Avanafil (Cas 330784-47-9) Price by States (2011-2016)

4 UNITED STATES AVANAFIL (CAS 330784-47-9) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Avanafil (Cas 330784-47-9) Sales and Market Share by Type (2011-2016)
4.2 United States Avanafil (Cas 330784-47-9) Revenue and Market Share by Type (2011-2016)
4.3 United States Avanafil (Cas 330784-47-9) Price by Type (2011-2016)
4.4 United States Avanafil (Cas 330784-47-9) Sales Growth Rate by Type (2011-2016)

5 UNITED STATES AVANAFIL (CAS 330784-47-9) SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Avanafil (Cas 330784-47-9) Sales and Market Share by Application (2011-2016)
5.2 United States Avanafil (Cas 330784-47-9) Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES AVANAFIL (CAS 330784-47-9) MANUFACTURERS PROFILES/ANALYSIS

6.1 VIVUS
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
    6.1.2.1 By Dosage
    6.1.2.2 50mg
  6.1.3 VIVUS Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Menarini Group
  6.2.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
    6.2.2.1 By Dosage
    6.2.2.2 50mg
  6.2.3 Menarini Group Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Auxilium Pharmaceuticals, Inc
  6.3.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
    6.3.2.1 By Dosage
    6.3.2.2 50mg
  6.3.3 Auxilium Pharmaceuticals, Inc Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
    6.4.2.1 By Dosage
    6.4.2.2 50mg
  6.4.3 Sanofi Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Endo International
  6.5.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
    6.5.2.1 By Dosage
    6.5.2.2 50mg
  6.5.3 Endo International Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 JW Pharmaceutical
  6.6.2 Avanafil (Cas 330784-47-9) Product Type, Application and Specification
    6.6.2.1 By Dosage
    6.6.2.2 50mg
  6.6.3 JW Pharmaceutical Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview

7 AVANAFIL (CAS 330784-47-9) MANUFACTURING COST ANALYSIS

7.1 Avanafil (Cas 330784-47-9) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Avanafil (Cas 330784-47-9)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Avanafil (Cas 330784-47-9) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Avanafil (Cas 330784-47-9) Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES AVANAFIL (CAS 330784-47-9) MARKET FORECAST (2016-2021)

11.1 United States Avanafil (Cas 330784-47-9) Sales, Revenue Forecast (2016-2021)
11.2 United States Avanafil (Cas 330784-47-9) Sales Forecast by Type (2016-2021)
11.3 United States Avanafil (Cas 330784-47-9) Sales Forecast by Application (2016-2021)
11.4 Avanafil (Cas 330784-47-9) Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Avanafil (Cas 330784-47-9)
Table Classification of Avanafil (Cas 330784-47-9)
Figure United States Sales Market Share of Avanafil (Cas 330784-47-9) by Type in 2015
Figure By Dosage Picture
Figure 50mg Picture
Figure 100mg Picture
Figure 200mg Picture
Figure By Purity Picture
Figure ≥99% Picture
Figure Other Picture
Table Application of Avanafil (Cas 330784-47-9)
Figure United States Sales Market Share of Avanafil (Cas 330784-47-9) by Application in 2015
Figure Pharmaceutical Examples
Figure Other Examples
Figure United States Avanafil (Cas 330784-47-9) Sales and Growth Rate (2011-2021)
Figure United States Avanafil (Cas 330784-47-9) Revenue and Growth Rate (2011-2021)
Table United States Avanafil (Cas 330784-47-9) Sales of Key Manufacturers (2015 and 2016)
Table United States Avanafil (Cas 330784-47-9) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Avanafil (Cas 330784-47-9) Sales Share by Manufacturers
Figure 2016 Avanafil (Cas 330784-47-9) Sales Share by Manufacturers
Table United States Avanafil (Cas 330784-47-9) Revenue by Manufacturers (2015 and 2016)
Table United States Avanafil (Cas 330784-47-9) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Avanafil (Cas 330784-47-9) Revenue Share by Manufacturers
Table 2016 United States Avanafil (Cas 330784-47-9) Revenue Share by Manufacturers
Table United States Market Avanafil (Cas 330784-47-9) Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Avanafil (Cas 330784-47-9) Average Price of Key Manufacturers in 2015
Figure Avanafil (Cas 330784-47-9) Market Share of Top 3 Manufacturers
Figure Avanafil (Cas 330784-47-9) Market Share of Top 5 Manufacturers
Table United States Avanafil (Cas 330784-47-9) Sales by States (2011-2016)
Table United States Avanafil (Cas 330784-47-9) Sales Share by States (2011-2016)
Figure United States Avanafil (Cas 330784-47-9) Sales Market Share by States in 2015
Table United States Avanafil (Cas 330784-47-9) Revenue and Market Share by States (2011-2016)
Table United States Avanafil (Cas 330784-47-9) Revenue Share by States (2011-2016)
Figure Revenue Market Share of Avanafil (Cas 330784-47-9) by States (2011-2016)
Table United States Avanafil (Cas 330784-47-9) Price by States (2011-2016)
Table United States Avanafil (Cas 330784-47-9) Sales by Type (2011-2016)
Table United States Avanafil (Cas 330784-47-9) Sales Share by Type (2011-2016)
Figure United States Avanafil (Cas 330784-47-9) Sales Market Share by Type in 2015
Table United States Avanafil (Cas 330784-47-9) Revenue and Market Share by Type (2011-2016)
Table United States Avanafil (Cas 330784-47-9) Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Avanafil (Cas 330784-47-9) by Type (2011-2016)
Table United States Avanafil (Cas 330784-47-9) Price by Type (2011-2016)
Figure United States Avanafil (Cas 330784-47-9) Sales Growth Rate by Type (2011-2016)
Table United States Avanafil (Cas 330784-47-9) Sales by Application (2011-2016)
Table United States Avanafil (Cas 330784-47-9) Sales Market Share by Application (2011-2016)
Figure United States Avanafil (Cas 330784-47-9) Sales Market Share by Application in 2015
Table United States Avanafil (Cas 330784-47-9) Sales Growth Rate by Application (2011-2016)
Figure United States Avanafil (Cas 330784-47-9) Sales Growth Rate by Application (2011-2016)
Table VIVUS Basic Information List
Table VIVUS Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure VIVUS Avanafil (Cas 330784-47-9) Sales Market Share (2011-2016)
Table Menarini Group Basic Information List
Table Menarini Group Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Menarini Group Avanafil (Cas 330784-47-9) Sales Market Share (2011-2016)
Table Auxilium Pharmaceuticals, Inc Basic Information List
Table Auxilium Pharmaceuticals, Inc Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Auxilium Pharmaceuticals, Inc Avanafil (Cas 330784-47-9) Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Avanafil (Cas 330784-47-9) Sales Market Share (2011-2016)
Table Endo International Basic Information List
Table Endo International Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Endo International Avanafil (Cas 330784-47-9) Sales Market Share (2011-2016)
Table JW Pharmaceutical Basic Information List
Table JW Pharmaceutical Avanafil (Cas 330784-47-9) Sales, Revenue, Price and Gross Margin (2011-2016)
Table JW Pharmaceutical Avanafil (Cas 330784-47-9) Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Avanafil (Cas 330784-47-9)
Figure Manufacturing Process Analysis of Avanafil (Cas 330784-47-9)
Figure Avanafil (Cas 330784-47-9) Industrial Chain Analysis
Table Raw Materials Sources of Avanafil (Cas 330784-47-9) Major Manufacturers in 2015
Table Major Buyers of Avanafil (Cas 330784-47-9)
Table Distributors/Traders List
Figure United States Avanafil (Cas 330784-47-9) Production and Growth Rate Forecast (2016-2021)
Figure United States Avanafil (Cas 330784-47-9) Revenue and Growth Rate Forecast (2016-2021)
Table United States Avanafil (Cas 330784-47-9) Production Forecast by Type (2016-2021)
Table United States Avanafil (Cas 330784-47-9) Consumption Forecast by Application (2016-2021)
Table United States Avanafil (Cas 330784-47-9) Sales Forecast by States (2016-2021)
Table United States Avanafil (Cas 330784-47-9) Sales Share Forecast by States (2016-2021)